Substituted quinazoline derivatives for use in gastrointestinal diseases
申请人:Smithkline Beecham Intercredit B.V.
公开号:US05064833A1
公开(公告)日:1991-11-12
2,4-diaminoquinazoline compounds are inhibitors of the H.sup.+ K.sup.+ ATPase enzyme and useful for the treatment of diseases of the stomach based on excessive gastric acid secretion. A compound of the invention is 2-[2-methyl-4-fluorophenyl)amino]-4-(N-methylphenylamino)quinazoline.